CALYPTE BIOMEDICAL CORP

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$5.1M

69 transactions

Summary

CALYPTE BIOMEDICAL CORP is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $2.5MSales: —17 insiders

Date	Insider	Type	Value
2008-07-21	Alsuwaidi Ahmed Abdulla Deemas	X	$496K
2008-06-17	Ahmed Mohamed	X	$300K
2008-06-18	Sulaiman Mohamed Yousif Ahmed Saleh	X	$100K
2008-06-16	Khidasheli David	X	$100K
2012-12-28	KARAS ADEL(President and CEO)	A	$0
2012-12-28	Edilashvili Kartlos(CFO and Secretary)	A	$0
2012-12-28	Al Yousefi Tareq	A	$0
2008-07-28	TAYLOR DONALD N(President and Chief Executive)	A	—
2008-07-21	Alsuwaidi Ahmed Abdulla Deemas	X	$0
2008-06-18	Sulaiman Mohamed Yousif Ahmed Saleh	X	$0
2008-06-17	Ahmed Mohamed	X	$0
2008-06-16	Khidasheli David	X	$0
2008-06-11	Khidasheli David	H	$0
2008-06-11	Khidasheli David	H	$0
2008-06-11	Khidasheli David	Buy	$0
2008-06-11	Khidasheli David	Buy	$0
2008-06-11	Ahmed Mohamed	H	$0
2008-06-11	Ahmed Mohamed	H	$0
2008-06-11	Ahmed Mohamed	Buy	$0
2008-06-11	Ahmed Mohamed	Buy	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

CALYPTE BIOMEDICAL CORP — Contributions, Lobbying & Contracts | Poliscope